EC updates guidance on devices with animal tissues
This article was originally published in Clinica
The European Commission has published a final draft of a revised guidance document (meddev) on devices utilising tissues or derivatives originating from animals for which a TSE risk is suspected. The purpose of the guidance is to aid the common application of Commission Directive 2003/32/EC on devices containing animal tissues by clarifying some aspects of its interpretation. In particular, it addresses the evaluation performed by the notified body, the activities of the co-ordinating competent authority and the verification role of the other competent authorities. Meddev 2.11/1 revision 2 is dated January 2008, and is available at: http://ec.europa.eu/enterprise/ medical-devices/meddev/2-11-1-rev2-bsetse-january2008.pdf
You may also be interested in...
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.